Lates News

According to the AI fast news, on April 28, TF Securities released a research report giving KaiLaiYing (002821.SZ) a rating of "buy". The main reasons for the rating include: 1) reducing costs and increasing efficiency, with all expense ratios decreasing year-on-year and month-on-month; 2) the performance of the main business of small molecule CDMO is stable, with rapid growth in revenue from emerging businesses and an increase in gross profit margin; 3) implementing a stock incentive plan to enhance company cohesion and employee enthusiasm. (Daily Economic News)